SCHEMBL6318773

SCHEMBL6318773

CCOC(=O)c1sc(Nc2nc(NCc3ccc4c(c3)OCO4)c3c(ncn3CC)n2)nc1C

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 4/20 0.75
PDE3A Q14432 4/20 0.75
PDE2A O00408 2/20 0.75
PDE5A O76074 6/20 0.66
MAPT P10636 3/20 0.49
PPP1CA P62136 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
KDM4E B2RXH2 2/20 0.49
POLB P06746 1/20 0.49
ALDH1A1 P00352 4/20 0.47
USP2 O75604 2/20 0.47
ALOX15 P16050 2/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
LMNA P02545 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
DHODH Q02127 1/20 0.44
CFTR P13569 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6326193 0.89 PDE3B (0.75) PDE3BPDE3APDE2APDE5AMAPT
SCHEMBL6325034 0.88 PDE3B (0.75) PDE3BPDE3APDE2APDE5AMAPT
SCHEMBL6325498 0.87 PDE3B (0.65) PDE3BPDE3APDE2APDE5AMAPT
SCHEMBL6319496 0.86 PDE3B (0.78) PDE3BPDE3APDE2APDE5AMAPT
SCHEMBL6319303 0.86 PDE3B (1.00) PDE3BPDE3APDE2APDE5AMAPT
SCHEMBL6317793 0.85 PDE3B (0.78) PDE3BPDE3APDE2APDE5AMAPT
SCHEMBL6323438 0.85 PDE3B (0.90) PDE3BPDE3APDE2APDE5AMAPT
SCHEMBL6318287 0.85 PDE3B (0.79) PDE3BPDE3APDE2APDE5AMAPT
SCHEMBL6317123 0.84 PDE3B (0.78) PDE3BPDE3APDE2APDE5AMAPT
SCHEMBL6317562 0.84 PDE3B (0.78) PDE3BPDE3APDE2APDE5AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6838559-B2 Purine inhibitors of phosphodiesterase (PDE) 7 BRISTOL-MYERS SQUIBB CO. (US) 2005-01-04 US claimed
EP-1501830-A1 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES Actelion Pharmaceuticals Ltd. (CH) 2005-02-02 EP disclosed
US-6838559-B2 Purine inhibitors of phosphodiesterase (PDE) 7 BRISTOL-MYERS SQUIBB CO. (US) 2005-01-04 US disclosed
WO-2003093267-A1 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES ACTELION PHARMACEUTICALS LTD (CH) 2003-11-13 WO disclosed